- Market Research
- Bone Marrow Transplantation Market Segmented by autologous bone marrow transplantation and allogeneic bone marrow transplantation Type with leukemia, lymphoma, myeloma, myelodysplasia, myeloproliferative neoplasms, aplastic anemia, solid tumors, sickle cell anemia, thalassemia Indication
Expanding Bone Marrow Donor Registry to Boost the Growth of the Bone Marrow Transplantation Market
Over the past few years, there has been a significant increase in the number of bone marrow registries. Increasing awareness, coupled with a rise in promotional campaigns run by healthcare practitioners, is majorly responsible for the rise in the number of bone marrow registries globally. The trend is especially quite prominent in developed regions.
The number of bone marrow donor registrants is comparatively lower in developing regions as compared to developed regions. For instance, the severe low presence of donors in China has drastically affected the market in the country. Low availability of HLA-matched bone marrow donors, coupled with the cost factor, has been severely (negatively) affecting the growth of the overall bone marrow transplantation market over the years.
Only around 40% patients, globally, receive bone marrow transplantation in a year. For a successful transplant, a patient needs a matching donor. Seventy percent (70%) of the patients cannot find a matching donor within their family. These patients will depend on a registry to help them find a donor.
The markers used in matching are inherited, hence, patients are more likely to match with someone from their own race or ethnicity, making it more difficult for minority ethnicities to find a match. With the expansion of bone marrow donor registries across the world, the market for bone marrow transplantation is expected to flourish during the forecast period.
Find Out More about the Report Coverage
- Merck Millipore Corporation
- Sanofi-Aventis LLC.
- STEMCELL Technologies.
- American Type Culture Collection (ATCC) Inc
- ReeLabs Pvt. Ltd.
Increased Survival Rate after Bone Marrow Transplantation Treatment to Potentially Boost Adoption
Over the past few years, there has been a considerable increase in patient survival rates after bone marrow transplantation, which is a major factor attributed to the increasing demand for conducting bone marrow transplantation procedures. It is the likely assured treatment option for end-stage leukemia and other blood cancers.
For instance, Mayo Foundation for Medical Education and Research reported 1 year survival rate of 73% among allogeneic BMT and 98% for autologous BMT in the U.S. in 2014.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Increasing Prevalence of Blood Cancer in Developing Regions is driving the Demand for Bone Marrow Transplantation
There has been a rise in the incidences of blood cancer in the past decade. The incidence rate of blood cancer is 1.5X higher in developing regions as compared to developed regions. Increase in per capita income in most of the developing regions has led to a significant rise in spending on healthcare.
This, in turn, is expected to boost the growth of the overall bone marrow transplantation market in the region.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Ease of Access to Bone Marrow Transplantation Therapy in the US
Availability of resources, such as national bone marrow registries, non-profit hematopoietic cell registries, national marrow donor programs, and other similar organizations, has granted patients an easy access to the otherwise difficult process of study, in the US. For instance, as per a study conducted in the US, there was a 5% increase in the bone marrow transplantation rate from 2009 to 2013.
Explore Persistence Market Research’s expertise in promulgation of the business !
Commercialization of Cellular Therapy and Tissue Engineering Products
Increasing market presence of many companies engaged in clinical trials of cellular therapy and tissue engineering products, in turn, is expected to increase the demand for bone marrow transplantation procedure worldwide.
Some of the companies have transpired from being R&D companies to full-fledged commercial companies. Some of them have witnessed above 30% growth in last 5 years. Stem cell graft is the fastest growing cellular therapy, the market for which was valued around US$ 510 Mn by the end of 2015.
Low Reimbursement and Payment Gaps for Bone Marrow Transplantation
Lack of reimbursement policies for organ transplantation procedure in developing regions, coupled with high cost of bone marrow transplantation, has led to the slower adoption of bone marrow transplantation procedure, particularly in developing regions. Only 30% of the global population has been found to be financially sound to undergo bone transplantation.
Limited coverage is further stressed by the CMS payment policy, which reimburses significantly low amount when compared to the actual cost of bone marrow transplantation. Federal reimbursement rate is 47% less than the procedure’s true cost. As a result, hospitals in the U.S. that perform marrow transplants for Medicare patients report losses of nearly $40,000 per transplant.
Bone marrow may be damaged or destroyed by disease, infection or chemotherapy. A medical procedure that is performed to replace damaged or destroyed bone marrow is known as bone marrow transplantation.
In an autologous transplant, stem cells are collected from the patient themselves, harvested, frozen, and stored, then infused back into the patient after intensive therapy. In an allogeneic transplant, stem cells are collected from a matching donor and transplanted into the patient to suppress the disease and restore the patient’s immune system.
About the Report
The report on the bone marrow transplantation market offers a comprehensive evaluation of the business opportunities in the bone marrow transplantation market along with insights on the competition blueprint, list of key players in the bone marrow transplantation market, and trend analysis of the bone marrow transplantation market for the duration from 2018 to 2028.
The report offers a comprehensive taxonomy of the bone marrow transplantation market based on transplantation type, indication, end user, and region. Based on transplantation type, the global bone marrow transplantation market is segmented into autologous bone marrow transplantation and allogeneic bone marrow transplantation.
Based on indication, the global bone marrow transplantation market is segmented into leukemia, lymphoma, myeloma, myelodysplasia, myeloproliferative neoplasms, aplastic anemia, solid tumors, sickle cell anemia, thalassemia and others. Based on the end user, the bone marrow transplantation market is segmented into hospitals, ambulatory surgical centers, and multispecialty clinics.
From a geographical perspective, the bone marrow transplantation market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA).
Additional Questions Answered
Some of the additional questions addressed in this report on the remedies market are-
- What is the revenue potential of the bone marrow transplantation market across emerging economies such as Brazil, Russia, and India?
- What are the factors driving the growth of the bone marrow transplantation market across the world?
- What are the major challenges influencing the growth of the bone marrow transplantation market?